4.8 Article

Circulating NOD1 Activators and Hematopoietic NOD1 Contribute to Metabolic Inflammation and Insulin Resistance

Journal

CELL REPORTS
Volume 18, Issue 10, Pages 2415-2426

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2017.02.027

Keywords

-

Categories

Funding

  1. Banting and Best Diabetes Centre (BBDC) of the University of Toronto
  2. Ontario Graduate Scholarship (OGS)
  3. BBDC
  4. CIHR Vanier Canada Graduate Studentship
  5. CIHR [MT-11219]
  6. CIHR Bone Team grant [TBO-122068]
  7. CIHRTeam [THC-135238]

Ask authors/readers for more resources

Insulin resistance is a chronic inflammatory condition accompanying obesity or high fat diets that leads to type 2 diabetes. It is hypothesized that lipids and gut bacterial compounds in particular contribute to metabolic inflammation by activating the immune system; however, the receptors detecting these instigators'' of inflammation remain largely undefined. Here, we show that circulating activators of NOD1, a receptor for bacterial peptidoglycan, increase with high fat feeding inmice, suggesting that NOD1 could be a critical sensor leading to metabolic inflammation. Hematopoietic depletion of NOD1 did not prevent weight gain but protected chimeric mice against diet-induced glucose and insulin intolerance. Mechanistically, while macrophage infiltration of adipose tissue persisted, notably these cells were less pro-inflammatory, had lower CXCL1 production, and consequently, lower neutrophil chemoattraction into the tissue. These findings reveal macrophage NOD1 as a cell-specific target to combat diet-induced inflammation past the step of macrophage infiltration, leading to insulin resistance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available